Multi-Target Computational Analysis of Monacolin X Against Angiogenesis-Associated Receptors
Physchem · 25.10.2026 · 6 (4) · 64
DOI: 10.3390/physchem6040064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physchem, online erschienen am 25.10.2026. Verfasst von Vennila Jayaraman und 7 weiteren Autor:innen. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Science and Technology.
Abstract (Originalsprache)
Breast cancer (BC) is a serious global health problem with increasing incidence and mortality, while current treatments are often associated with severe side effects and drug resistance. Therefore, new therapeutic agents with enhanced efficacy and minimal adverse effects are needed. Our previous study reported the anti-angiogenic effect of Monacolin X, a secondary metabolite of a marine-sponge-associated fungus, using combined in vitro, ex vivo, in vivo (including a DMBA-induced mammary carcinoma rat model) and in silico approaches, identifying VEGFR2 as its principal target. In this study, molecular docking and molecular dynamics (MD) simulations were performed to investigate the interactions between Monacolin X and key anti-angiogenic targets, including IGFR, EGFR, neuropilin 1 (NRP1), Tie-2, VEGFR1/2, and PDGFRα, using Schrödinger Glide XP. Selective inhibitors were used for comparison. Docking analysis showed significant binding affinities of Monacolin X toward IGFR (G-score = −9.05), PDGFRα (−7.57), VEGFR1 (−7.42), Tie-2 (−7.40), VEGFR2 (−7.515), EGFR (−6.80), and NRP1 (−5.15), with hydrogen bonding, hydrophobic contacts, and electrostatic interactions contributing to stable complexes. Notably, IGFR and Tie-2 exhibited strong interactions, suggesting potential inhibition of angiogenic signaling. MD simulations were performed for 50 ns at 300 K and 1 bar; complex stability was assessed using RMSD and RMSF analyses, and the persistence of key active site hydrogen bonds was quantified as a percentage of simulation frames. MM-PBSA binding free-energy calculations further supported the thermodynamic feasibility of these interactions. Overall, these findings highlight Monacolin X’s potential as an anti-angiogenic agent for BC. However, further in vitro and in vivo studies are required to validate its efficacy and clinical relevance.
Förderung
- Department of Science and Technology
Zitieren
APA
Jayaraman, V., Arumugam, M. K., Nagabhishek, S. N., Balachandran, S., Jayaraman, J., Nandhagopal, C., Bharathi, M., & Gopal, T. (2026). Multi-Target Computational Analysis of Monacolin X Against Angiogenesis-Associated Receptors. Physchem, 6(4), 64. https://doi.org/10.3390/physchem6040064
Vancouver
Jayaraman V, Arumugam MK, Nagabhishek SN, Balachandran S, Jayaraman J, Nandhagopal C, et al. Multi-Target Computational Analysis of Monacolin X Against Angiogenesis-Associated Receptors. Physchem. 2026;6(4):64. doi:10.3390/physchem6040064
BibTeX
@article{Jayaraman2026,
author = {Jayaraman, Vennila and Arumugam, Madan Kumar and Nagabhishek, Sirpu Natesh and Balachandran, Shana and Jayaraman, Jayaprakash and Nandhagopal, Chandru and Bharathi, Muruganantham and Gopal, Thiyagarajan},
title = {Multi-Target Computational Analysis of Monacolin X Against Angiogenesis-Associated Receptors},
journal = {Physchem},
year = {2026},
volume = {6},
number = {4},
pages = {64},
doi = {10.3390/physchem6040064}
}
EUVIMED